✦ LIBER ✦

Transfer factor in restoration of cell mediated immunity in lung cancer patients

✍ Scribed by Takehiko Fujisawa; Yutaka Yamaguchi; Hideki Kimura

Book ID: 112755268
Publisher: Springer
Year: 1983
Tongue: English
Weight: 503 KB
Volume: 13
Category: Article
ISSN: 1436-2813
DOI: 10.1007/bf02469511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transfer factor: Therapy in patients wit

Transfer factor: Therapy in patients with deficient cell-mediated immunity and deficient antibody-mediated immunity

✍ Arthur J. Ammann; Diane Wara; Sydney Salmon 📂 Article 📅 1974 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Impaired cell-mediated immunity in patie

Impaired cell-mediated immunity in patients with cancer

✍ Dr. Joseph A. Buda; N. Suciu-Foca; Eric Blomain; Susan McManus; Keith Reemtsma 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Factors contributing to deficiencies in

Factors contributing to deficiencies in cell-mediated immunity in esophageal cancer patients

✍ Takao Saito; Akihiko Kuwahara; Katsuhiro Shimoda; Tadahiko Kinoshita; Akira Naka 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 443 KB

Passive transfer of cell-mediated immuni

Passive transfer of cell-mediated immunity in xenogeneic animals

✍ Steven S. Rosenfeld; Jeffrey D. Bernhard; Edmund Klein 📂 Article 📅 1973 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Restoration of immunity in lymphopenic i

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

✍ Rapoport, Aaron P; Stadtmauer, Edward A; Aqui, Nicole; Badros, Ashraf; Cotte, Ju 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 314 KB

Cell-mediated immune response in head an

Cell-mediated immune response in head and neck cancer patients

✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m